CATALOGO DEI PRODOTTI DELLA RICERCA

BRUNELLI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.764
EU - Europa 24.996
AS - Asia 16.789
SA - Sud America 2.554
Continente sconosciuto - Info sul continente non disponibili 961
AF - Africa 577
OC - Oceania 51
Totale 74.692
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.776
RU - Federazione Russa 9.414
SG - Singapore 6.388
CN - Cina 4.982
GB - Regno Unito 4.693
IT - Italia 3.521
BR - Brasile 1.971
VN - Vietnam 1.519
HK - Hong Kong 1.518
DE - Germania 1.445
SE - Svezia 1.436
FR - Francia 1.124
IE - Irlanda 1.114
FI - Finlandia 854
CA - Canada 612
KR - Corea 547
BD - Bangladesh 383
IN - India 284
NL - Olanda 270
UA - Ucraina 253
JP - Giappone 241
AR - Argentina 194
TR - Turchia 183
MX - Messico 170
ES - Italia 152
PL - Polonia 148
NG - Nigeria 126
BE - Belgio 120
ZA - Sudafrica 110
ID - Indonesia 107
IQ - Iraq 106
CO - Colombia 94
EC - Ecuador 89
AT - Austria 80
LT - Lituania 75
PK - Pakistan 67
VE - Venezuela 67
TG - Togo 62
MA - Marocco 55
BJ - Benin 52
SA - Arabia Saudita 51
CL - Cile 50
UZ - Uzbekistan 44
AU - Australia 43
CZ - Repubblica Ceca 41
JM - Giamaica 41
PH - Filippine 41
PY - Paraguay 37
MY - Malesia 34
CR - Costa Rica 32
AE - Emirati Arabi Uniti 30
TN - Tunisia 29
EG - Egitto 27
JO - Giordania 27
KE - Kenya 27
IR - Iran 26
AZ - Azerbaigian 25
PT - Portogallo 22
HN - Honduras 21
LV - Lettonia 21
CH - Svizzera 20
DZ - Algeria 20
AL - Albania 19
KZ - Kazakistan 19
PE - Perù 18
IL - Israele 17
RO - Romania 17
RS - Serbia 17
NP - Nepal 16
DK - Danimarca 15
GR - Grecia 15
PA - Panama 15
UY - Uruguay 15
BO - Bolivia 14
DO - Repubblica Dominicana 14
EE - Estonia 14
PS - Palestinian Territory 14
BG - Bulgaria 13
TT - Trinidad e Tobago 13
CI - Costa d'Avorio 12
SN - Senegal 12
HU - Ungheria 11
NI - Nicaragua 11
TH - Thailandia 11
KG - Kirghizistan 10
LB - Libano 10
AM - Armenia 9
ET - Etiopia 9
GT - Guatemala 9
HR - Croazia 9
LK - Sri Lanka 9
NO - Norvegia 9
PR - Porto Rico 9
BY - Bielorussia 8
CY - Cipro 8
EU - Europa 8
MD - Moldavia 8
OM - Oman 8
SV - El Salvador 8
TW - Taiwan 8
Totale 73.572
Salva come PNG Salva come JPEG
Città #
Southend 3.738
Ashburn 3.617
Singapore 3.429
Moscow 3.163
San Jose 2.723
Chandler 2.472
Dallas 2.341
Hong Kong 1.491
Jacksonville 1.342
Dublin 1.100
Woodbridge 1.072
Beijing 1.022
Council Bluffs 1.016
Ann Arbor 960
Verona 918
The Dalles 759
New York 744
Los Angeles 615
Houston 531
Munich 486
Ho Chi Minh City 472
Lawrence 369
Princeton 367
Wilmington 346
Jinan 332
Hanoi 315
Helsinki 309
Santa Clara 286
Nanjing 248
São Paulo 239
Milan 238
Buffalo 232
Shenyang 229
Rome 225
Tokyo 221
Montréal 195
Columbus 181
Mcallen 179
Hebei 175
Tianjin 175
Orem 169
Redondo Beach 169
London 160
Montreal 160
Turku 145
Sindelfingen 134
Dearborn 131
Frankfurt am Main 128
Zhengzhou 127
Denver 122
Warsaw 120
Seattle 119
Redmond 118
Abuja 115
Brussels 113
Seoul 112
Chicago 107
Ningbo 106
Brooklyn 105
Changsha 105
Guangzhou 104
Bologna 102
Atlanta 99
Toronto 98
Boardman 96
Phoenix 95
Taizhou 94
Stockholm 93
Chennai 91
Haikou 88
Amsterdam 84
Nanchang 80
Mexico City 76
Redwood City 74
Hangzhou 72
San Francisco 71
Johannesburg 70
Taiyuan 70
Jiaxing 66
Lancaster 66
Rio de Janeiro 65
Haiphong 61
Lomé 61
Poplar 61
Da Nang 59
Dong Ket 57
Boston 56
Washington 56
Manchester 55
Norwalk 54
Cotonou 52
Las Vegas 52
Madrid 52
Volga 47
Belo Horizonte 45
Detroit 45
Nuremberg 45
Vienna 45
Jakarta 44
Baghdad 43
Totale 44.181
Salva come PNG Salva come JPEG
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 916
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 682
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 389
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 347
Una complessa valutazione della vitalità delle fratture in ambito forense 335
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 330
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 297
Autophagy pathways in drug abusers after forensic autopsy: LC3B, ph-mTOR and p70S6K analysis 278
Schwannoma del rene 272
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 271
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience 266
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 265
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 263
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 263
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 260
Combining interphase and metaphase analyses in the differential diagnosis among renal cell neoplasms with distal nephron differentiation 258
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 256
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 255
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 255
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 250
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 242
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 239
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 239
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 238
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 237
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 237
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 234
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 232
Consultation between forensic and clinical pathologists for histopathology examination after forensic autopsy 231
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 230
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 230
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 229
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 229
CD10 is expressed in a subset of chromophobe renal cell carcinomas 228
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 228
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 226
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 226
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 225
Adenocarcinoma of the paraurethral glands: a case report 225
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 225
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 224
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 224
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 223
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 222
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 221
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 221
Chondroid syringoma with extensive ossification 221
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 220
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 219
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 218
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 217
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 216
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 216
Liver Metastases From Renal Oncocytoma With Vascular Extension 214
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 213
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 213
Extended pelvic lymphadenectomy for prostate cancer: should the cloquet's nodes dissection be considered only an option? 212
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 212
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 212
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 210
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 210
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 210
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis 210
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 210
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 209
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 209
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 208
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 208
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 208
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 208
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 208
Consultation interface between Pathologist and Forensic Science Experts for histopathology examination 208
Donor-Transmitted Cancers in Transplanted Livers: Analysis of Clinical Outcomes 207
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 206
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 206
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 205
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 205
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 204
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 204
[Small cell carcinoma of the bladder. Report of 3 cases and review of the literature] 204
A pseudotumoral lesion diagnosed for a hypertrofic fibrosis at the proximal stump in anterior tibialis tendon missed rupture: a case report 203
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 202
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 202
Diagnostic concordance between whole slide imaging and conventional light microscopy in cytopathology: A systematic review 201
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 201
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series 200
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 200
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 200
[Diagnostic and prognostic markers in renal tumors] 199
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 199
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 199
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 199
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 198
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 198
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 197
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 197
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 197
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 197
'Case of the Month' from the University of Verona, Italy-navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 197
Briganti's 2012 nomogram is an independent predictor of prostate cancer progression in EAU intermediate-risk class: results from 527 patients treated with robotic surgery 196
Totale 23.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 257.108
article - articoli 234.899
book - libri 0
conference - conferenze 21.639
curatela - curatele 0
other - altro 570
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 514.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.953 0 0 0 338 150 132 50 208 93 85 232 665
2022/20237.040 459 772 615 1.188 606 1.737 72 482 765 72 162 110
2023/20244.072 172 300 326 446 481 669 198 246 67 279 638 250
2024/202510.115 507 544 549 1.653 428 351 576 448 1.427 685 982 1.965
2025/202632.309 2.056 1.612 2.350 5.577 8.286 2.116 2.687 1.640 2.688 1.903 561 833
2026/20274.202 486 830 1.149 1.737 0 0 0 0 0 0 0 0
Totale 74.692